These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12649748

  • 21. Paclitaxel inhibits natural killer cell binding to target cells by down-regulating adhesion molecule expression.
    Loubani O, Hoskin DW.
    Anticancer Res; 2005; 25(2A):735-41. PubMed ID: 15868904
    [Abstract] [Full Text] [Related]

  • 22. Role of CD11a/CD18-CD54 interactions in suppression of human B cell responsiveness by CD4+ suppressor T cells.
    Hirohata S.
    Cell Immunol; 1992 Dec; 145(2):272-86. PubMed ID: 1360336
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.
    Symington FW, Santos EB.
    J Immunol; 1991 Apr 01; 146(7):2169-75. PubMed ID: 1672345
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antigen-adjuvant effects of icariin in enhancing tumor-specific immunity in mastocytoma-bearing DBA/2J mice.
    Zhang X, Kang Z, Li Q, Zhang J, Cheng S, Chang H, Wang S, Cao S, Li T, Li J, Wang Y, Song Y, Yu H.
    Biomed Pharmacother; 2018 Mar 01; 99():810-816. PubMed ID: 29710479
    [Abstract] [Full Text] [Related]

  • 30. Expression of the adhesion molecules ICAM-1 and ICAM-2 on tumor cell lines does not correlate with their susceptibility to natural killer cell-mediated cytolysis: evidence for additional ligands for effector cell beta integrins.
    Akella R, Hall RE.
    Eur J Immunol; 1992 Apr 01; 22(4):1069-74. PubMed ID: 1348028
    [Abstract] [Full Text] [Related]

  • 31. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D, Viale O, Cerruti G, Tenca C, Malorni W, Arancia G, Iosi F, Galandrini R, Velardi A, Moretta A.
    Cell Immunol; 1992 Sep 01; 143(2):389-404. PubMed ID: 1380897
    [Abstract] [Full Text] [Related]

  • 32. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S, Black J, English DP, Schwab CL, Lopez S, Cocco E, Bonazzoli E, Predolini F, Ferrari F, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD.
    Am J Obstet Gynecol; 2016 Jan 01; 214(1):99.e1-8. PubMed ID: 26272866
    [Abstract] [Full Text] [Related]

  • 33. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
    Tohma S, Hirohata S, Lipsky PE.
    J Immunol; 1991 Jan 15; 146(2):492-9. PubMed ID: 1670945
    [Abstract] [Full Text] [Related]

  • 34. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells.
    Fawcett H, Mader JS, Robichaud M, Giacomantonio C, Hoskin DW.
    Int J Oncol; 2005 Dec 15; 27(6):1717-26. PubMed ID: 16273228
    [Abstract] [Full Text] [Related]

  • 35. Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes.
    Nagy E, Baral E, Kangas L, Berczi I.
    Anticancer Res; 1997 Dec 15; 17(2A):1083-8. PubMed ID: 9137453
    [Abstract] [Full Text] [Related]

  • 36. Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization.
    Frick M, Mouchacca P, Verdeil G, Hamon Y, Billaudeau C, Buferne M, Fallet M, Auphan-Anezin N, Schmitt-Verhulst AM, Boyer C.
    Immunology; 2017 Feb 15; 150(2):199-212. PubMed ID: 27716898
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.